We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should You Invest in the ARK Genomic Revolution Multi-Sector ETF (ARKG)?
Read MoreHide Full Article
Launched on 10/31/2014, the ARK Genomic Revolution Multi-Sector ETF (ARKG - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
While an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional and retail investors due to their low costs, transparency, flexibility, and tax efficiency.
Sector ETFs are also funds of convenience, offering many ways to gain low risk and diversified exposure to a broad group of companies in particular sectors. Healthcare - Broad is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 5, placing it in top 31%.
Index Details
The fund is sponsored by Ark Investment Management. It has amassed assets over $302.13 M, making it one of the average sized ETFs attempting to match the performance of the Healthcare - Broad segment of the equity market.
This ETF is active and does not track a benchmark.
Costs
Cost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive counterparts if all other fundamentals are the same.
Annual operating expenses for this ETF are 0.75%, making it one of the most expensive products in the space.
Sector Exposure and Top Holdings
Even though ETFs offer diversified exposure which minimizes single stock risk, it is still important to look into a fund's holdings before investing. Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis.
Looking at individual holdings, Intellia Therapeutics Inc (NTLA - Free Report) accounts for about 10.61% of total assets, followed by Invitae Corp and Illumina Inc (ILMN - Free Report) .
The top 10 holdings account for about 56.80% of total assets under management.
Performance and Risk
So far this year, ARKG return is roughly 34.10%, and it's up approximately 29.65% in the last one year (as of 09/12/2018). During this past 52-week period, the fund has traded between $23.87 and $34.45.
The ETF has a beta of 1.72 and standard deviation of 28.03% for the trailing three-year period, making it a high risk choice in the space. With about 37 holdings, it has more concentrated exposure than peers.
Bottom Line
To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Should You Invest in the ARK Genomic Revolution Multi-Sector ETF (ARKG)?
Launched on 10/31/2014, the ARK Genomic Revolution Multi-Sector ETF (ARKG - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
While an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional and retail investors due to their low costs, transparency, flexibility, and tax efficiency.
Sector ETFs are also funds of convenience, offering many ways to gain low risk and diversified exposure to a broad group of companies in particular sectors. Healthcare - Broad is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 5, placing it in top 31%.
Index Details
The fund is sponsored by Ark Investment Management. It has amassed assets over $302.13 M, making it one of the average sized ETFs attempting to match the performance of the Healthcare - Broad segment of the equity market.
This ETF is active and does not track a benchmark.
Costs
Cost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive counterparts if all other fundamentals are the same.
Annual operating expenses for this ETF are 0.75%, making it one of the most expensive products in the space.
Sector Exposure and Top Holdings
Even though ETFs offer diversified exposure which minimizes single stock risk, it is still important to look into a fund's holdings before investing. Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis.
Looking at individual holdings, Intellia Therapeutics Inc (NTLA - Free Report) accounts for about 10.61% of total assets, followed by Invitae Corp and Illumina Inc (ILMN - Free Report) .
The top 10 holdings account for about 56.80% of total assets under management.
Performance and Risk
So far this year, ARKG return is roughly 34.10%, and it's up approximately 29.65% in the last one year (as of 09/12/2018). During this past 52-week period, the fund has traded between $23.87 and $34.45.
The ETF has a beta of 1.72 and standard deviation of 28.03% for the trailing three-year period, making it a high risk choice in the space. With about 37 holdings, it has more concentrated exposure than peers.
Bottom Line
To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.